The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Evaluation of insulin sensitivity and secretion in primary aldosteronism
Abstract
In primary aldosteronism (PA), insulin response to glucose is not fully understood. Insulin action was elucidated using indices in 32 PA and 21 essential hypertension (EH) patients. These patients were evaluated using homeostasis model assessment (HOMA) indices, quantitative insulin sensitivity check index (QUICKI), and insulinogenic index (IGI), which were expressed for insulin sensitivity/secretion and the early phase of insulin secretion. Insulin sensitivity and early phase of insulin secretion were decreased in PA, and there was a negative correlation between serum potassium concentration and insulin sensitivity indices. These findings suggest that glucose intolerance in PA may be caused by hypokalemia-induced insulin resistance and hypokalemia-independent impairment of early-phase insulin secretion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, when compared with normotensive cohorts, reduced insulin sensitivity has been reported in PA patients [19,9,20,13,8,21,22].”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [21]
In the citing paper
“Additionally, Watanabe et al. suggest a hypokalemia-independent impairment of early-phase insulin response to glucose in PA.”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [21]
In the citing paper
“However, the effects of hyperaldosteronism on insulin sensitivity and β-cell function are unclear.”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [21]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Assessment of insulin sensitivity/resistance
Gutch, M., Kumar, S., Razi, S., Gupta, K., & Gupta, A. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.146874 · Cited by 555 · cited 1×
“The QUICKI is similar to HOMA-IR; however, the log-transformation included in the QUICKI formula results in greater accuracy than the HOMA-IR over a broad range of insulin sensitivity as well as a stronger correlation with hyper-insulinemic euglycemic clamp data (13).”
MethodFardella, C. E., Mosso, L., Gómez-Sánchez, C., Cortés, P., Soto, J., Gómez, L., Pinto, M., Huete, A., Oestreicher, E., Foradori, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6596 · Cited by 463
Hypertension, the Potassium Ion and Impaired Carbohydrate Tolerance
Conn, J. W. (1965) · New England Journal of Medicine · doi:10.1056/nejm196511182732106 · Cited by 329 · cited 2×
“Primary aldosteronism (PA) is a clinical syndrome characterized by hypokalemia, hypertension, and impaired glucose tolerance that was first reported by Conn in 1965 (1).”
BackgroundSelection of the appropriate method for the assessment of insulin resistance
Borai, A., Livingstone, C., Kaddam, I., & Ferns, G. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-158 · Cited by 268
Insulin Sensitivity in Patients with Primary Aldosteronism: A Follow-Up Study
Catena, C., Lapenna, R., Baroselli, S., Nadalini, E., Colussi, G., Novello, M., Favret, G., Melis, A., Cavarape, A., & Sechi, L. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0736 · Cited by 262
Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly
Melmed, S. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.12.3395 · Cited by 196
QUICKI is a useful index of insulin sensitivity in subjects with hypertension
Chen, H., Sullivan, G., Yue, L. Q., Katz, A., & Quon, M. J. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00330.2002 · Cited by 159
Research works printed but not linked: 4
- Melmed S, 1995, J Clin Endocrinol Metab, 80, 3395
- Fardella CE, 2000, J Clin Endocrinol Metab, 85, 1863
- Shimamoto K, 1994, J Hum Hypertens, 8, 755
- Widimský J, 2000, Physiol Res, 49, 241
Cited by
Secondary diabetes mellitus due to primary aldosteronism
Moustaki, M., Paschou, S. Α., Vakali, E., & Vryonidou, A. (2022) · Endocrine · doi:10.1007/s12020-022-03168-8 · Cited by 30
“Accordingly, in a study of PA patients showing insulin resistance and impaired 1st phase of insulin secretion, only the indices of insulin sensitivity (HOMA-IR and quantitative insulin sensitivity index check, QUICKI) were negatively with potassium level; no correlation between insulinogenic index (IGI) and potassium…”
BackgroundLin, M., Heizati, M., Wang, L., Nurula, M., Yang, Z., Wang, Z., Abudoyreyimu, R., Wu, Z., & Li, N. (2021) · Blood Pressure · doi:10.1080/08037051.2021.1880881 · Cited by 27
“Except for increasing BP, aldosterone also causes the aggravation of insulin resistance and diabetes by damaging islet endothelial function [10,11].”
BackgroundWan, X., Perry, J. A., Zhang, H., Feng, J., Ryan, K. A., Hout, C. V. V., Reid, J. G., Overton, J. D., Baras, A., Han, Z., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020071030 · Cited by 23
Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism
Grewal, S., Fosam, A., Chalk, L., Deven, A., Suzuki, M., Correa, R. R., Blau, J. E., Demidowich, A. P., Stratakis, C. A., & Muniyappa, R. (2021) · Endocrine · doi:10.1007/s12020-020-02576-y · Cited by 20
“While HOMA-β between their PA and EHC cohorts were comparable, IGI was significantly reduced in PA [21].”
BackgroundManosroi, W., Phudphong, P., Atthakomol, P., & Phimphilai, M. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01135-y · Cited by 20
Metadata
- Authors
- Watanabe, D., Yatabe, M., & Ichihara, A.
- Affiliations
- Tokyo Women's Medical University (JP)
- Corresponding author
- Watanabe, Daisuke
- Venue
- Clinical and Experimental Hypertension
- Publisher
- Informa UK Limited
- Published
- 2016-09-26
- Volume
- 38
- Issue
- 7
- Pages
- 613-617
- ISSN
- 0148-3927 (ISSN-L)
- 1064-1963
- 1525-6006
- OpenAlex
- W2525831663
- Semantic Scholar
- 0b9b8a323c01d4c05aa783712144d4a7797bc804
- Cited by
- 16
- References
- 22
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 2
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical and Experimental Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- primary aldosteronism, insulin sensitivity, insulin secretion, first-phase insulin secretion, insulin resistance, hypokalemia, impaired glucose tolerance, essential hypertension, HOMA, QUICKI, insulinogenic index, serum potassium
- MeSH terms
- Essential Hypertension, Insulin Secretion, Aged, Female, Glucose, Glucose Tolerance Test, Humans, Hyperaldosteronism, Hypertension, Hypokalemia, Insulin, Insulin Resistance, Male, Middle Aged, Potassium, Statistics as Topic, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of insulin sensitivity and secretion in primary aldosteronism. https://app.cochat.ai/papers/10.1080/10641963.2016.1182176
- The paper
- Watanabe, D., Yatabe, M., & Ichihara, A. (2016). Evaluation of insulin sensitivity and secretion in primary aldosteronism. Clinical and Experimental Hypertension. https://doi.org/10.1080/10641963.2016.1182176
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.